Cargando…
Tanshinone IIA suppresses the progression of lung adenocarcinoma through regulating CCNA2-CDK2 complex and AURKA/PLK1 pathway
Lung adenocarcinoma (LUAD) belongs to a subgroup of non-small cell lung cancer (NSCLC) with an increasing incidence all over the world. Tanshinone IIA (TSA), an active compound of Salvia miltiorrhiza Bunge., has been found to have anti-tumor effects on many tumors, but its anti-LUAD effect and its m...
Autores principales: | Li, Ziheng, Zhang, Ying, Zhou, Yuan, Wang, Fuqian, Yin, Chao, Ding, Li, Zhang, Shunbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654884/ https://www.ncbi.nlm.nih.gov/pubmed/34880385 http://dx.doi.org/10.1038/s41598-021-03166-2 |
Ejemplares similares
-
Preparation and characterisation of solid dispersions of tanshinone IIA, cryptotanshinone and total tanshinones
por: Zhai, Xifeng, et al.
Publicado: (2017) -
Tanshinones suppress AURKA through up-regulation of miR-32 expression in non-small cell lung cancer
por: Ma, Zhong-Liang, et al.
Publicado: (2015) -
Tanshinone IIA suppresses ovarian cancer growth through inhibiting malignant properties and angiogenesis
por: Zhou, Jin, et al.
Publicado: (2020) -
Effect of Supplementation of Tanshinone IIA and Sodium Tanshinone IIA Sulfonate on the Anticancer Effect of Epirubicin: An In Vitro Study
por: Chan, Szu-Erh, et al.
Publicado: (2011) -
Tanshinone Inhibits NSCLC by Downregulating AURKA Through Let-7a-5p
por: Liu, Xiaomin, et al.
Publicado: (2020)